|Articles|May 16, 2022
Direct LC-MS Characterization of Glycoform Distribution and Low Molecular Weight Impurities in mAb Process
Author(s)Waters Corporation
Using the BioAccord LC-MS System and an Ambr® 15, we developed an analytical method for rapid mAb glycoform confirmations and mAb purity assessments. This unique method is high throughput capable and has the potential to be a fully automated platform for mid-process intraday monitoring of CQAs.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Novartis Calls for Global Governments to Address Global Trade Policy
3
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
4
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
5